Baylor College of Medicine has named Dr. Alexander G. Izaguirre as vice president and chief technology officer to lead the College's integrated technology efforts in clinical, educational and translational research programs.

Izaguirre, who has an M.B.A and a Ph.D., is the acting executive director of the Office of Strategic Initiatives at the Robert Wood Johnson Medical School. His appointment at BCM is effective Feb. 20.

"Dr. Izaguirre is a visionary leader in academic medicine information technology," said Dr. Paul E. Klotman, president and CEO of Baylor College of Medicine. "His expertise across research technology and IT strategic development will be important in our efforts to advance all of our mission areas."

He has been with Robert Wood Johnson since 2006, first as director of the Office of Information Technology and then serving as the leader of the Office of Strategic Initiatives. He also has served as director of research technology development at New Jersey Medical School and as president and co-founder of WEAV Inc., a company he began as a graduate student to help faculty with technology needs.

He has served as an assistant professor in the Department of Molecular Genetics, Microbiology and Immunology at Robert Wood Johnson since 2005.

"The Texas Medical Center is an ideal setting for developing and introducing solutions that truly address translational research, patient centered medicine, and group based learning. Known for its excellence as an academic medical center, Baylor College of Medicine can and should serve as the epicenter for the development of next generation technologies aimed at reshaping the health sciences landscape."

In his role at BCM, Izaguirre will report to the president and have management responsibility for corporate information technology and other IT-related positions within the organization. He will serve as strategic leader for all IT initiatives. His responsibilities will include maximizing the research component of BCM's intellectual capital efforts.

Izaguirre will also hold an appointment in the Department of Medicine.

He received bachelor of science degrees in psychology and biology from Rutgers University and a doctorate degree in viral immunology from the Graduate School of Biomedical Sciences at University of Medicine and Dentistry of New Jersey. He earned a master's in business administration from Rutgers, with a pharmaceutical focus, and completed the Patent Law Review at the Practising Law Institute of New York.